Parapharm Development Limited
09948940
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 12/01/2026
Due 26/01/2027
Industry
Officers
secretary · Since 31/03/2020
director · Since 31/03/2020
DIRECTOR
BRITISH · ENGLAND · Age 44
Also on 1 other board
Persons with Significant Control
Nordic Pharma Limited
Building 1410, Arlington Business Park, Theale, RG7 4SA
Reg: 01489084 · Companies House · Limited Company
Notified 12/07/2024
Former PSCs
Mr Frederik Dag Arfst Paulsen
Ceased 12/07/2024
CompanyRankvs 419+ SIC 46460 peers73
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£7.4M
Balance sheet strength
Cash
£191k
Cash in the bank
Net Current Assets
£7.6M
Working capital
Current Assets
£7.6M
Current Liabilities
£27k
Debtors
£7.4M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 282.89 | +£5.1M |
| 2023 | 2.07 | — |
Derived from filed accounts. Not audited figures.